The Immunomodulatory Effects of Oral Nanocurcumin in Multiple Sclerosis Patients (Q66044279)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The Immunomodulatory Effects of Oral Nanocurcumin in Multiple Sclerosis Patients |
clinical trial |
Statements
The Effects of Oral Nanocurcumin on Expression Levels of microRNAs and Treg Cells and Th17 Cells Development Factors in Multiple Sclerosis Patients (English)
0 references
8 June 2016
0 references
10 August 2017
0 references
41
0 references
18 year
0 references
65 year
0 references